MedPath

Evaluation of Alvora Gel in Inflammatory Factors in Patients with Periodontitis

Phase 4
Recruiting
Conditions
Periodontitis.
Chronic periodontitis
K05.3
Registration Number
IRCT20100412003690N11
Lead Sponsor
Tabriz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
34
Inclusion Criteria

Moderate to severe ?chronic periodontitis
Age 35-50
Have at least 4 teeth with probe depth of 4 mm or more in each jaw quadrant
Consent to participate in the study
Patients candidate for non-surgical treatment

Exclusion Criteria

Allergy to aloe vera or its products
Use of tobacco
Endodontic and periodontal compound lesions
Periapical lesions
Pregnancy
Severe dental caries
Semi-impacted teeth
Orthodontic patients
Systemic diseases and systemic or topical antibiotic users 6 Months befor study
Patients with periodontal disease during the past 6 months and patients receiving periodontal treatment 6 months before study
Patients receiving NSAIDs one month before sampling

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Plaque Index (PI). Timepoint: Before entrance in the study and 30 days after initial treatment. Method of measurement: Using the index (O'Leary 1972).;Gingival Index (GI). Timepoint: Before entrance in the study and 30 days after initial treatment. Method of measurement: According to the Loe & Sillness Index.;Probe depth (PD). Timepoint: Before entrance in the study and 30 days after initial treatment. Method of measurement: Using Williams probe 6 levels of teeth.;IL-1B. Timepoint: Before entrance in the study and 30 days after initial treatment. Method of measurement: Using ELISA kit.;IL-17. Timepoint: Before entrance in the study and 30 days after initial treatment. Method of measurement: Using ELISA kit.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath